Decrease in the size of the myotonic dystrophy CTG repeat during transmission from parent to child: Implications for genetic counselling and genetic anticipation

1993 ◽  
Vol 45 (3) ◽  
pp. 401-407 ◽  
Author(s):  
Alasdair G. W. Hunter ◽  
Pierre Jacob ◽  
Kim O'Hoy ◽  
Ian MacDonald ◽  
Gabrielle Mettler ◽  
...  
2017 ◽  
Vol 27 (12) ◽  
pp. 1106-1114 ◽  
Author(s):  
N.M. Murillo-Melo ◽  
L.C. Márquez-Quiróz ◽  
R. Gómez ◽  
L. Orozco ◽  
E. Mendoza-Caamal ◽  
...  

2004 ◽  
Vol 61 (6) ◽  
pp. 895 ◽  
Author(s):  
Suad Alfadhli ◽  
Alaa E. Elshafey ◽  
Lailá Bastaki ◽  
Sadeqa Al-Awadi

1995 ◽  
Vol 41 (1) ◽  
pp. 69-72 ◽  
Author(s):  
M Guida ◽  
R S Marger ◽  
A C Papp ◽  
P J Snyder ◽  
M S Sedra ◽  
...  

Abstract Myotonic dystrophy (DM) is an autosomal dominant genetic disease caused by an unstable CTG repeat sequence in the 3' untranslated region of the myotonin protein kinase gene. The CTG repeat is present 5-30 times in the normal population, whereas DM patients have CTG expansions of 50 to several thousand repeats. The age of onset of the disorder and the severity of the phenotype is roughly correlated with the size of the CTG expansion. We developed a molecular protocol for the diagnosis of DM based on an initial polymerase chain reaction screen to detect normal-sized alleles and small expansions, followed by an improved Southern protocol to detect larger expansions.


2020 ◽  
Vol 13 (1) ◽  
Author(s):  
Yu Saito ◽  
Kenta Matsumura ◽  
Misao Kageyama ◽  
Yuichi Kato ◽  
Eiji Ohta ◽  
...  

2002 ◽  
Vol 59 (5) ◽  
pp. 350-355 ◽  
Author(s):  
J Finsterer ◽  
E Gharehbaghi-Schnell ◽  
C Stöllberger ◽  
K Fheodoroff ◽  
A Seiser

Author(s):  
Jean Mathieu ◽  
Marcel Simard ◽  
Marc De Braekeleer ◽  
Camil Boily ◽  
Aurèle Deschênes

ABSTRACT:The neurological and ophthalmological investigation of 602 members of 88 Saguenay kindreds affected by myotonic dystrophy (MyD) revealed 130 persons with a partial syndrome. These patients, whose average age was 34.1 years, showed different abnormalities such as particular ophthalmic and/or neuro-muscular signs, suggesting MyD in the absence of myotonia or typical lens abnormalities. After an average period of 2,4 years, 44 of these 130 patients were reassessed by the same neurologists and ophthalmologists. Thirty still had a partial syndrome, 8 showed a typical form of MyD and 6 no longer presented any identifiable anomaly. This preliminary follow-up study of the partial MyD syndrome did not allow us to identify any clinical anomaly from which the presence of the MyD gene could be predicted in a significant way. It furthermore suggested that the identification of equivocal or unspecific signs among these patients can sometimes lead to misdiagnosis. This must be taken into account when providing genetic counselling. It furthermore indicates that the use of DNA probes is essential for a reliable identification of asymptomatic MyD gene carriers.


2005 ◽  
Vol 47 (7) ◽  
pp. 478-485 ◽  
Author(s):  
Anna-Karin Kroksmark ◽  
Anne-Berit Ekström ◽  
Eva Björck ◽  
Már Tulinius

2002 ◽  
Vol 17 (11) ◽  
pp. 3003-3004 ◽  
Author(s):  
N. L. Dean ◽  
S. J. Phillips ◽  
P. Chan ◽  
S. L. Tan ◽  
A. Ao

Sign in / Sign up

Export Citation Format

Share Document